US prize-winning cancer scientist Wan Fengyi joins China’s Zhejiang University
A Johns Hopkins University scientist whose award-winning work suggests that a brief stomach bug could raise the risk of colon cancer has moved to China full time. Wan Fengyi, a professor at the Johns Hopkins Bloomberg School of Public Health, has joined Zhejiang University in Hangzhou, according to his new profile on the Chinese university’s website. Wan returned to China this month and now holds a chair professorship at Zhejiang University. He is based at a national laboratory at its Second...
Where: China
Exact coordinates
china: 35.860, 104.200
Read it at South China Morning Post See this on the map
What might happen next? AI-generated
These scenarios are written by an AI language model from the headline and summary above. They are not predictions from the newsroom, and they are not evidence of anything. Every one is given a deadline and checked against later coverage, and the score is published on the ledger — including the ones that miss.
-
Awaiting deadline 60% Standard Academic Integration
Zhejiang University officially inaugurates Wan Fengyi’s new laboratory facility, highlighting his research on gastric pathogens and colon cancer as a key asset to China’s biomedical goals. The US State Department issues no formal sanctions or restrictions on his work, treating the move as a routine academic transition with no national security implications.
Watch for: Zhejiang University hosts a formal inauguration ceremony for Wan Fengyi's new research lab in Hangzhou. · US State Department spokesperson declines to comment on Wan Fengyi's employment, citing it as a private academic matter.
-
Awaiting deadline 25% Regulatory Audit Initiated
US NIH or NSF officials initiate a retrospective review of Wan Fengyi’s past funding records to ensure no classified or restricted technology transfer occurred prior to his departure. This results in a formal inquiry letter being sent to Johns Hopkins University, signaling early-stage scrutiny despite the lack of immediate public outrage.
Watch for: US National Institutes of Health announces a routine compliance audit of former grant recipients moving abroad. · Johns Hopkins University confirms receipt of a regulatory inquiry regarding Dr. Wan Fengyi's past project data.
-
Awaiting deadline 10% Diplomatic Friction Over IP
Watch for: US Congress member introduces a letter questioning the export controls on medical research data shared with Chinese institutions. · NSF pauses approval of two pending collaborative grants between Johns Hopkins and Zhejiang University.
-
Awaiting deadline 5% Counter-Trajectory: Sanction Announcement
The US Commerce Department unexpectedly adds Wan Fengyi to the Entity List or imposes specific travel bans, citing national security risks related to his dual-use research capabilities. This drastic move triggers an immediate diplomatic protest from China and a sharp media backlash against the characterization of basic cancer research.
Watch for: US Department of Commerce announces sanctions against Wan Fengyi for alleged national security violations. · Chinese Foreign Ministry issues a strong statement condemning the US action as 'politically motivated' and 'unjustified.'
Generated by Qwen3.6-35B-A3B-UD-Q4_K_S.gguf
on 2026-10-19. Checked against later coverage after 2026-10-26.
See how these forecasts score.
ForecastGeo shows the headline and summary published by the newsroom and places the story on a map. The full article lives at the source.